Expert Perspectives in mBC
Abbreviations: 1L, 1st Line; 2L, 2nd Line; CDK4/6i, cyclin-dependent kinase 4/6 inhibitor; ESR1, estrogen receptor 1; ESR1m, estrogen receptor 1 mutation; ET, endocrine therapy; mBC, metastatic breast cancer.
Abbreviations: 1L, 1st Line; 2L, 2nd Line; CDK4/6i, cyclin-dependent kinase 4/6 inhibitor; ESR1, estrogen receptor 1; ESR1m, estrogen receptor 1 mutation; ET, endocrine therapy; mBC, metastatic breast cancer.
